About Trajectory
Innovation Insights
Investments
Contact

Search

Iambic Therapeutics

Iambic Therapeutics taps Lambda for AI compute to develop the next generation of AI molecular property prediction for drug discovery

Iambic Therapeutics, a CNBC 2025 Disruptor 50 Company developing novel medicines using its…

by Peter Bordes

Recent Posts

Via Satellite announced Lynk and Omnispace merger among the 10 Hottest Companies in Satellite for 2026
Securitize and Uniswap Labs collaborate to unlock liquidity options for BlackRock’s BUIDL
Humanoid robotics innovator Apptronik closes $935 Million Series A at $5 Billion valuation
Aerospace innovator Natilus raises $28 Million Series A to commercialize hyper efficient blended wing aircraft
Natilus aerospace unveils new hyper efficient HORIZON EVO blended wing aircraft as it readies for FAA Certification and commercial fleet integration

Categories

Space Innovation
BIG Tech
Entrepreneurs
Fintech Innovation
Cyber Security Innovation
AI Innovation
Data Innovation
Ecommerce Innovation
Blockchain Innovation
Ad Tech
Leadership
Product Launch
Disruptive Innovators
M&A
Investments News
Aerospace Innovation
Robotics Innovation
Defense Tech Innovation
SPACs
Venture Capital

Copyright 2022. Trajectory Capital Partners LLC. All Rights Reserved

Privacy Preference Center

Privacy Preferences

Pin It on Pinterest